CD274 and head and neck cancer: For instance, it has been shown that PD-L1 CAR NK cells not only eradicate cancer cells expressing PD-L1 molecule but also reduce levels of TAMs and other myeloid cells endogenously expressing a high level of PD-L1 in peripheral blood from patients with head and neck cancer [181].